another recommendation on seeking alpha

In addition to its previous coverage on Seeking Alpha, QRX has again been identified as a top stock to watch:

http://seekingalpha.com/article/2129933-8-biotech-events-to-anticipate-this-year-part-two

The FDA Advisory Committee is now less than two weeks away (Tuesday 22 April). while the PDUFA date is less than 7 weeks away (25 May).

Both dates should serve as potent catalysts for share price change, though it is the PDUFA date that will serve as the ultimate determinant of both QRX's share price and the company's future.